Search research articles
Contact Us
Filters
Showing results (1-10 of 124) with videos related to
Page
of 13
Sort By:
Current Opinion in Rheumatology
|
February 17, 2017
Treatment of lupus nephritis: current paradigms and emerging strategies
Maria Dall'Era
Current Opinion in Rheumatology
|
July 2, 2011
Mycophenolate mofetil in the treatment of systemic lupus erythematosus
Maria Dall'Era
Nature Reviews. Rheumatology
|
June 4, 2009
Systemic lupus erythematosus clinical trials-an interim analysis
Maria Dall'Era, David Wofsy
Journal of Thrombosis and Haemostasis : JTH
|
June 18, 2026
Refining thrombotic risk in membranous lupus nephritis: is anti-C1q the missing link?
Savino Sciascia, Maria Dall'Era
Current Opinion in Rheumatology
|
August 10, 2006
Clinical trial design in systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Nature Reviews. Rheumatology
|
March 4, 2010
Connective tissue diseases: Belimumab for systemic lupus erythematosus: breaking through?
Maria Dall'Era, David Wofsy
Discovery Medicine
|
January 28, 2010
Biologic therapy for systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Postgraduate Medicine
|
December 3, 2003
Systemic lupus erythematosus. How to manage, when to refer
Maria Dall'Era, John C Davis
Current Rheumatology Reports
|
May 18, 2011
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies
Maria Dall'era, Eliza F Chakravarty
Rheumatology (Oxford, England)
|
September 15, 2022
The use of combination monoclonal antibody therapies in lupus-where are we now?
Joana Rua, Maria Dall'Era, David Isenberg
Page
of 13
Search research articles
Search
Showing results (1-10 of 124) with videos related to
Sort By:
Page
of 13
Current Opinion in Rheumatology
|
February 17, 2017
Treatment of lupus nephritis: current paradigms and emerging strategies
Maria Dall'Era
Current Opinion in Rheumatology
|
July 2, 2011
Mycophenolate mofetil in the treatment of systemic lupus erythematosus
Maria Dall'Era
Nature Reviews. Rheumatology
|
June 4, 2009
Systemic lupus erythematosus clinical trials-an interim analysis
Maria Dall'Era, David Wofsy
Journal of Thrombosis and Haemostasis : JTH
|
June 18, 2026
Refining thrombotic risk in membranous lupus nephritis: is anti-C1q the missing link?
Savino Sciascia, Maria Dall'Era
Current Opinion in Rheumatology
|
August 10, 2006
Clinical trial design in systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Nature Reviews. Rheumatology
|
March 4, 2010
Connective tissue diseases: Belimumab for systemic lupus erythematosus: breaking through?
Maria Dall'Era, David Wofsy
Discovery Medicine
|
January 28, 2010
Biologic therapy for systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Postgraduate Medicine
|
December 3, 2003
Systemic lupus erythematosus. How to manage, when to refer
Maria Dall'Era, John C Davis
Current Rheumatology Reports
|
May 18, 2011
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies
Maria Dall'era, Eliza F Chakravarty
Rheumatology (Oxford, England)
|
September 15, 2022
The use of combination monoclonal antibody therapies in lupus-where are we now?
Joana Rua, Maria Dall'Era, David Isenberg
Page
of 13